Daniela M.
- Country
- Bulgaria
- Department
- -
Research Overview
Data & Insights
Has run more than one trial at 61 of 152 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in the management of severe hypertriglyceridemia (SHTG), a serious metabolic condition characterized by abnormally high levels of triglycerides in the blood.
- Lipid Metabolism Disorders
- Cardiovascular Risk Management
- Metabolic Disease Treatment
Their research focuses on innovative therapeutic approaches for treating elevated triglyceride levels.
Clinical Therapeutics
The investigator's work centers on evaluating novel therapeutic agents for metabolic disorders, with particular emphasis on investigating treatments that target lipid metabolism pathways.
- Novel Drug Development
- Treatment Safety Assessment
- Therapeutic Efficacy Studies
Their expertise includes assessment of innovative medications for managing severe lipid disorders.
Patient Care
The investigator is involved in developing treatment strategies for patients with severe lipid disorders, focusing on both safety and efficacy outcomes in clinical practice.
- Patient Monitoring
- Treatment Optimization
- Clinical Outcomes Assessment
Their work emphasizes comprehensive patient care approaches in metabolic disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.